• Bookmark and Share

New Law Funds Postpartum Depression Screening

Last Updated on Wednesday, January 04, 2017

After more than two years in the making, federal legislation known as the 21st Century Cures Act passed Congress and was signed into law. The landmark legislation was one of the final bills signed into law by President Obama. In addition to providing support for research at the National Institutes of Health (NIH) and resources for new drug and device approval at the Food and Drug Administration (FDA), the bill also seeks to improve and support programs and policies for maternal health and mental health.

"The Preeclampsia Foundation strongly supports this increased funding to address postpartum depression, highlighting its direct link to the adverse outcomes often associated with preeclampsia, and the need to ensure a woman's health is supported during pre-conception, pregnancy, and the postpartum period," said Eleni Tsigas, Executive Director. 

The legislation provides resources for the screening of and treatment for maternal depression, authorizing $20 million over four years for state grant funding to establish, improve, and maintain programs for screening, assessment, and treatment services for maternal depression for women who are pregnant or have recently given birth.

States applying for grants will have to demonstrate how a program will increase the number of women screened and treated for maternal depression and improve access to those services. Priority will be given to states that enhance access to screening services for maternal depression in primary care settings. States that are awarded grants will be required to use funds to provide training for healthcare providers and develop materials for providers on screening, treatment, and follow-up support services. Awarded states will be permitted to use funding to link women to community mental health resources and support groups and utilize telehealth services for rural and underserved areas.

The new law also establishes an interagency task force to address the lack of existing research into the safety of prescription drugs and other medications used by pregnant and lactating women. The Preeclampsia Foundation supports clinical trials to identify safe medications that can help treat chronic conditions and also support new therapeutics to address preeclampsia.


We’ll be Speaking Here


National WIC Conference

Washington, DC

March 3, 2019


GRIVAS Conference

Chillan, Chile

April 4 - 6, 2019


Lamaze Live!

Pittsburgh, Pennsylvania

April 12, 2019


AWHONN Indiana

Indianapolis, Indiana

August 23, 2019


  Invite Us to Speak at Your Event


Featured Video

What’s Happening on Twitter

preeclampsia Joint Commission, getting tough on #maternalhealth, proposes mandatory childbirth safety standards for hospitals to… https://t.co/SG3ZAUxlpp
preeclampsia This #BlackMaternalHealthWeek (April 11-17) we're proud to join @BlkMamasMatter and Black women across the U.S. to… https://t.co/FyMj3owVR4
preeclampsia @AMAGPharma CEO William Heiden makes the case for investing in women's health. As our newest Corporate Partner, AMA… https://t.co/hNyGmXkXhP

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.